申请人:Bexel Pharmaceuticals Inc.
公开号:US07365069B2
公开(公告)日:2008-04-29
The present invention relates to novel pyrimidones of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly novel pyrimidones of the general formula (I)
本发明涉及一种新的嘧啶酮,其一般式为(I),其衍生物,类似物,互变异构体,立体异构体,多晶形态,水合物,溶剂化物,药学上可接受的盐以及含有它们的药学上可接受的组合物。本发明更具体地涉及一种新的嘧啶酮,其一般式为(I)。